Figure S4 from Quantification of Translocation-Specific ctDNA Provides an Integrating Parameter for Early Assessment of Treatment Response and Risk Stratification in Ewing Sarcoma

Authors:

Abstract
Quantified mean ctDNA levels (fusion gene/ALB copies) before (VIDE1A) and after (VIDE1E) the first chemotherapy block separated according to different clinical risk criteria. The upper graphs show results for localized disease, the lower graphs show results for metastatic disease.